Everence Capital Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,490
| Closed | -$219K | – | 803 |
|
|
2025
Q1 | $219K | Sell |
2,490
-350
| -12% | -$33K | 0.01% | 712 |
|
|
2024
Q4 | $259K | Buy |
+2,840
| New | +$291K | 0.02% | 655 |
|
|
2022
Q4 | – | Sell |
-3,900
| Closed | -$277K | – | 762 |
|
|
2022
Q3 | $277K | Hold |
3,900
| – | – | 0.03% | 537 |
|
|
2022
Q2 | $350K | Hold |
3,900
| – | – | 0.03% | 459 |
|
|
2022
Q1 | $437K | Hold |
3,900
| – | – | 0.03% | 450 |
|
|
2021
Q4 | $472K | Hold |
3,900
| – | – | 0.04% | 445 |
|
|
2021
Q3 | $393K | Hold |
3,900
| – | – | 0.03% | 479 |
|
|
2021
Q2 | $455K | Hold |
3,900
| – | – | 0.04% | 420 |
|
|
2021
Q1 | $429K | Sell |
3,900
-4,460
| -53% | -$484K | 0.04% | 425 |
|
|
2020
Q4 | $838K | Buy |
8,360
+4,840
| +138% | +$449K | 0.08% | 205 |
|
|
2020
Q3 | $275K | Hold |
3,520
| – | – | 0.03% | 484 |
|
|
2020
Q2 | $240K | Buy |
+3,520
| New | +$222K | 0.03% | 522 |
|
|
2020
Q1 | – | Sell |
-3,520
| Closed | -$279K | – | 653 |
|
|
2019
Q4 | $279K | Hold |
3,520
| – | – | 0.04% | 497 |
|
|
2019
Q3 | $260K | Hold |
3,520
| – | – | 0.04% | 474 |
|
|
2019
Q2 | $274K | Hold |
3,520
| – | – | 0.05% | 450 |
|
|
2019
Q1 | $267K | Hold |
3,520
| – | – | 0.05% | 449 |
|
|
2018
Q4 | $257K | Hold |
3,520
| – | – | 0.06% | 319 |
|
|
2018
Q3 | $337K | Hold |
3,520
| – | – | 0.07% | 297 |
|
|
2018
Q2 | $352K | Hold |
3,520
| – | – | 0.07% | 280 |
|
|
2018
Q1 | $372K | Hold |
3,520
| – | – | 0.08% | 266 |
|
|
2017
Q4 | $326K | Hold |
3,520
| – | – | 0.07% | 282 |
|
|
2017
Q3 | $319K | Hold |
3,520
| – | – | 0.07% | 283 |
|
|
2017
Q2 | $296K | Hold |
3,520
| – | – | 0.07% | 290 |
|
|
2017
Q1 | $284K | Hold |
3,520
| – | – | 0.07% | 283 |
|
|
2016
Q4 | $265K | Sell |
3,520
-2,050
| -37% | -$148K | 0.08% | 284 |
|
|
2016
Q3 | $377K | Hold |
5,570
| – | – | 0.11% | 218 |
|
|
2016
Q2 | $378K | Hold |
5,570
| – | – | 0.12% | 217 |
|
|
2016
Q1 | $402K | Hold |
5,570
| – | – | 0.13% | 210 |
|
|
2015
Q4 | $376K | Hold |
5,570
| – | – | 0.12% | 210 |
|
|
2015
Q3 | $360K | Hold |
5,570
| – | – | 0.12% | 208 |
|
|
2015
Q2 | $456K | Hold |
5,570
| – | – | 0.15% | 193 |
|
|
2015
Q1 | $415K | Hold |
5,570
| – | – | 0.14% | 198 |
|
|
2014
Q4 | $423K | Buy |
+5,570
| New | +$440K | 0.14% | 196 |
|
Other funds holding EMN
Everence Capital Management's EMN Position: Q2 2025 in Review
Everence Capital Management sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 2,490 shares — an estimated $219K sold.
Everence Capital Management first reported a position in EMN in Q4 2014 and held it in 33 quarters. The position peaked at $838K in Q4 2020. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.
- Everence Capital Management reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
- Everence Capital Management sold 2,490 Eastman Chemical shares in Q2 2025, an estimated $219K.
- Everence Capital Management first reported a position in Eastman Chemical in Q4 2014 and held it in 33 quarters.
- Everence Capital Management's Eastman Chemical position peaked at $838K in Q4 2020.
- 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.
Based on Everence Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.